Efficacy of anti-PD-1 antibodies in NSCLC patients with an EGFR mutation and high PD-L1 expression
暂无分享,去创建一个
Y. Ohe | Midori Tanaka | N. Yamamoto | H. Horinouchi | Y. Goto | Y. Okuma | Y. Matsumoto | Tatsuya Yoshida | Y. Shinno | K. Masuda | R. Higashiyama | J. Sato | T. Yoshida